APA (7th ed.) Citation

Petrini, I., Pardini, E., Cucchiara, F., Sardo Infirri, G., Burzi, I., Barachini, S., . . . Lucchi, M. (2024). 1922P Targeted resequencing designed specifically for thymic epithelial tumours confirmed the high prevalence of GTF2I mutations. Annals of Oncology, 35, S1118. https://doi.org/10.1016/j.annonc.2024.08.2004

Chicago Style (17th ed.) Citation

Petrini, I., et al. "1922P Targeted Resequencing Designed Specifically for Thymic Epithelial Tumours Confirmed the High Prevalence of GTF2I Mutations." Annals of Oncology 35 (2024): S1118. https://doi.org/10.1016/j.annonc.2024.08.2004.

MLA (9th ed.) Citation

Petrini, I., et al. "1922P Targeted Resequencing Designed Specifically for Thymic Epithelial Tumours Confirmed the High Prevalence of GTF2I Mutations." Annals of Oncology, vol. 35, 2024, p. S1118, https://doi.org/10.1016/j.annonc.2024.08.2004.